OncoLink Cancer Treatment and Resources
OncoLink Cancer Treatment and Resources

NCI Resources

 
NCI CANCERLIT® Search: Malignant Mesothelioma - October 2001
Immunohistochemical MIB-1 and p27kip1 as prognostic factors in pleural mesothelioma. Synovial sarcoma and malignant mesothelioma of the pleura: review, differential diagnosis and possible role of apoptosis. Prognostic significance of flow...
NCI CANCERLIT® Search: Malignant Mesothelioma - September 2001
Table of ContentsMethionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity.Endothelial nitric oxide synthase is strongly expressed in malignant mesothelioma but does not associate...
NCI CANCERLIT® Search: Malignant Mesothelioma - April 2002
[Treatment of malignant pleural mesothelioma] [Pleural mesothelioma in women in the Veneto Region who used to work as rag sorters for textile recycling and paper production] [Malignant mesothelioma: clinical and radiological description of 45 ...
NCI CANCERLIT® Search: Malignant Mesothelioma - August 2002
Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells. Changing attitudes and opinions regarding asbestos and cancer 1934-1965. Influence of Cremophor El on the bioavailability of...
NCI CANCERLIT® Search: Malignant Mesothelioma - February 2002
Eve of the third millennium, providing an update on the management of non-small cell lung cancer (NSCLC). [Multi-targeted antifolate therapy roe non-small cell lung cancer and mesothelioma] Additional proteins in BAL fluid of Metsovites...
NCI CANCERLIT® Search: Malignant Mesothelioma - January 2002
Early diagnosis of mesothelioma in serous effusions using AgNOR analysis. [Occupational exposure to asbestos and recognition of pleural mesothelioma as occupational disease in the province of Genoa] Significant augmentation of...
NCI CANCERLIT® Search: Malignant Mesothelioma - July 2002
Expression of glycoprotein 90K in human malignant pleural mesothelioma: correlation with patient survival. [Considerations upon diagnosis and treatment of lung and pleural tumors in Mures county] Open access follow-up for lung cancer:...
NCI CANCERLIT® Search: Malignant Mesothelioma - June 2002
Asbestos and its lethal legacy. Phosphatase and tensin analog gene overexpression engenders cellular death in human malignant mesothelioma cells via inhibition of AKT Overexpression of peroxiredoxins I, II, III, V, and VI in malignant ...
NCI CANCERLIT® Search: Malignant Mesothelioma - March 2002
The epidemiology of mesothelioma. The role of imaging in malignant pleural mesothelioma. Prognostic factors in mesothelioma. Multimodality treatment of diffuse malignant pleural mesothelioma. Diagnosis and treatment of peritoneal mesothelioma: The...
NCI CANCERLIT® Search: Malignant Mesothelioma - May 2002
Expression of telomerase reverse transcriptase (TERT) in malignant mesotheliomas. Malignant pleural mesothelioma. Manganese superoxide dismutase genotypes and asbestos-associated pulmonary disorders. Expression of p21 in SV40 large T...
NCI CANCERLIT® Search: Malignant Mesothelioma - October 2002
Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma. Occupational and environmental thoracic malignancies. Imaging of thoracic occupational and environmental malignancies. Incidence of malignant pleural...
NCI CANCERLIT® Search: Malignant Mesothelioma - September 2002
Current therapy for malignant mesothelioma. Current surgical management of malignant pleural mesothelioma. Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma. Molecular...
NCI/PDQ® Health professionals: Lung Cancer Prevention (PDQ®)
TABLE OF CONTENTS OverviewWho is at Risk?Factors associated with increased risk of lung cancerCigarette smokingExposure to secondhand smokeRadon exposureFactors of uncertain association with riskDietary factorsPhysical activityInterventions...
NCI/PDQ® Health professionals: Lung Cancer Screening (PDQ®)
TABLE OF CONTENTS OverviewEvidence of Benefit Associated With ScreeningScreening by low-dose helical computed tomographyBenefitsHarmsEvidence of No Benefit Associated With ScreeningScreening by chest x-ray and/or sputum cytologyBenefitsHarmsFalse...
NCI/PDQ® Health professionals: Malignant Mesothelioma Treatment (PDQ®)
TABLE OF CONTENTS General Information About Malignant Mesothelioma TreatmentCellular Classification of Malignant MesotheliomaStage Information for Malignant MesotheliomaDefinitions of TNMTreatment Option OverviewLocalized Malignant Mesothelioma...
NCI/PDQ® Pacientes: Mesotelioma maligno: Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre el mesotelioma malignoEstadios del mesotelioma malignoMesotelioma maligno recidivanteAspectos generales de las opciones de tratamientoOpciones de tratamiento para el mesotelioma malignoMesotelioma...
NCI/PDQ® Patients: Lung Cancer Prevention (PDQ®)
TABLE OF CONTENTS What is prevention?General Information About Lung CancerLung Cancer PreventionChanges to This Summary (05/24/2012)Questions or Comments About This SummaryGet More Information From NCIAbout PDQ® What is prevention? Back UpCancer...
NCI/PDQ® Patients: Lung Cancer Screening (PDQ®)
TABLE OF CONTENTS What is screening?General Information About Lung CancerLung Cancer ScreeningRisks of Lung Cancer ScreeningChanges to This Summary (11/02/2012)Questions or Comments About This SummaryGet More Information From NCIAbout PDQ® What...
NCI/PDQ® Patients: Lung Cancer Screening (PDQ®)
TABLE OF CONTENTS What is screening?General Information About Lung CancerLung Cancer ScreeningRisks of Lung Cancer ScreeningChanges to This Summary (11/02/2012)Questions or Comments About This SummaryGet More Information From NCIAbout PDQ® What...
NCI/PDQ® Patients: Malignant Mesothelioma Treatment (PDQ®)
TABLE OF CONTENTS General Information About Malignant MesotheliomaStages of Malignant MesotheliomaRecurrent Malignant MesotheliomaTreatment Option OverviewTreatment Options for Malignant Mesothelioma Localized Malignant Mesothelioma (Stage...
NCI/PDQ® Profesionales De Salud: Mesotelioma maligno: Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre el tratamiento del mesotelioma malignoClasificación celular del mesotelioma malignoInformación sobre los estadios del mesotelioma malignoDefiniciones TNMAspectos generales de las opciones...
OncoLink I wish u knew...

3D mammography, also known as digital tomosynthesis, is a new technology aimed at having better detection of abnormalities and fewer false positives. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS